PMID: 11910586Mar 26, 2002Paper

Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding

Climacteric : the Journal of the International Menopause Society
E HirvonenA C Bäckström

Abstract

To assess the acceptability, efficacy and endometrial safety of transdermal estradiol gel (Divigel/Sandrena) combined with monthly or quarterly oral progestogen (medroxyprogesterone acetate). This 12-month, multicenter, open-label study was carried out at 12 study centers in Finland and Sweden. A total of 395 postmenopausal women received 1 mg estradiol in 1 g gel, daily, with oral medroxyprogesterone acetate 10 mg for the first 12 days every month (groups I and III) or every 3 months (group II). The main outcome measures were relief of climacteric symptoms, bleeding patterns and endometrial safety. All regimens reduced the severity of hot flushes, sweating episodes and vaginal dryness. In groups I and III, approximately 80% and 70% of women, respectively, had regular monthly withdrawal bleeding (excepting the first cycle), with irregular bleeding in 8.3% and 5.3% of treatment months. In group II, approximately 94% of women had regular tri-monthly withdrawal bleeding, with irregular bleeding in 10.7% of the treatment months. Endometrial hyperplasia was observed in 0.3% of women. More than 87% of subjects completed the study, and 97% of these rated the gel as acceptable or convenient. Both the 1- and 3-month regimens were equall...Continue Reading

References

Jul 1, 1992·Annals of Internal Medicine·E G LufkinB L Riggs
May 1, 1987·American Journal of Obstetrics and Gynecology·W H Utian
Nov 5, 1987·The New England Journal of Medicine·D P KielM A Moskowitz
Feb 1, 1981·British Journal of Obstetrics and Gynaecology·S LyrenäsB von Schoultz
Sep 1, 1995·American Journal of Obstetrics and Gynecology·R A Lobo
Sep 1, 1995·American Journal of Obstetrics and Gynecology·L E Nachtigall
Sep 1, 1995·The Journal of Clinical Endocrinology and Metabolism·T V NguyenJ A Eisman
Apr 14, 1994·The New England Journal of Medicine·P E Belchetz
Oct 29, 1993·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R BarentsenA C Drogendijk
Oct 14, 1993·The New England Journal of Medicine·D T FelsonJ J Anderson
Jan 1, 1996·Obstetrics and Gynecology·B EttingerC P Quesenberry
Dec 9, 1997·British Journal of Obstetrics and Gynaecology·E HirvonenG Wilén-Rosenqvist

❮ Previous
Next ❯

Citations

Sep 22, 2000·Current Review of Pain·S R Anderson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.